These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8429683)

  • 1. Role of transforming growth factor-beta in chronic lymphocytic leukemia.
    Israels LG; Israels SJ; Begleiter A; Verburg L; Schwartz L; Mowat MR; Johnston JB
    Leuk Res; 1993 Jan; 17(1):81-7. PubMed ID: 8429683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors.
    Lagneaux L; Delforge A; Bron D; Massy M; Bernier M; Stryckmans P
    Br J Haematol; 1997 Jun; 97(3):612-20. PubMed ID: 9207409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.
    DeCoteau JF; Knaus PI; Yankelev H; Reis MD; Lowsky R; Lodish HF; Kadin ME
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5877-81. PubMed ID: 9159168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
    Lotz M; Ranheim E; Kipps TJ
    J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
    Schuler M; Tretter T; Schneller F; Huber C; Peschel C
    Immunobiology; 1999 Feb; 200(1):128-39. PubMed ID: 10084701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia.
    Lagneaux L; Delforge A; Bernier M; Stryckmans P; Bron D
    Leuk Lymphoma; 1998 Sep; 31(1-2):99-106. PubMed ID: 9720719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of transforming growth factor-beta in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-beta by leukemic cells.
    Johnston JB; Dalal BI; Israels SJ; Oh S; McMillan E; Begleiter A; Michaud G; Israels LG; Greenberg AH
    Am J Clin Pathol; 1995 May; 103(5):574-82. PubMed ID: 7741102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.
    Schiemann WP; Rotzer D; Pfeifer WM; Levi E; Rai KR; Knaus P; Kadin ME
    Cancer Detect Prev; 2004; 28(1):57-64. PubMed ID: 15041079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell chronic lymphocytic leukaemia cells express and release transforming growth factor-beta.
    Kremer JP; Reisbach G; Nerl C; Dörmer P
    Br J Haematol; 1992 Apr; 80(4):480-7. PubMed ID: 1581232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of cytokines released by bone marrow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients.
    Lagneaux L; Delforge A; Bron D; Bosmans E; Stryckmans P
    Leuk Lymphoma; 1995 Mar; 17(1-2):127-33. PubMed ID: 7773149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.
    Douglas RS; Capocasale RJ; Lamb RJ; Nowell PC; Moore JS
    Blood; 1997 Feb; 89(3):941-7. PubMed ID: 9028325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
    Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
    Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
    Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
    J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
    Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
    J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus.
    Su HC; Leite-Morris KA; Braun L; Biron CA
    J Immunol; 1991 Oct; 147(8):2717-27. PubMed ID: 1918986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells.
    Romano S; Mallardo M; Chiurazzi F; Bisogni R; D'Angelillo A; Liuzzi R; Compare G; Romano MF
    Haematologica; 2008 Jul; 93(7):1039-48. PubMed ID: 18492692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
    Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK
    Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
    Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
    Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TGF-beta - SMAD pathway is inactivated in cronic lymphocytic leukemia cells.
    Matveeva A; Kovalevska L; Kholodnyuk I; Ivanivskaya T; Kashuba E
    Exp Oncol; 2017 Dec; 39(4):286-290. PubMed ID: 29284776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.